Document Detail


Overweight treated with energy restriction and a dietary fibre supplement: a 6-month randomized, double-blind, placebo-controlled trial.
MedLine Citation:
PMID:  2172178     Owner:  NLM     Status:  MEDLINE    
Abstract/OtherAbstract:
Fifty-two (41 females, 11 males) overweight patients, mean body mass index (BMI) = 29.3, were treated for 6 months in a randomized, double-blind, placebo-controlled, parallel group design. The treatment consisted of an energy restricted diet and a dietary fibre supplement amounting to 7 g/day. After treatment the weight reduction in the fibre-treated group, 5.5 +/- 0.7 kg, was significantly higher than that of the placebo group, 3.0 +/- 0.5 kg (P = 0.005). Both groups were normotensive and comparable commencing treatment, 126.5/75.6 +/- 2.0/1.3 mm Hg versus 126.7/78.7 +/- 2.5/1.6 mm Hg. The treatment changed blood pressure non-significantly. Hunger feelings using visual analogue scales (VAS) were significantly reduced from 139.8 +/- 8.2 cm to 118.3 +/- 7.0 cm in the fibre-treated group, whereas a significant increase from 129.5 +/- 6.9 cm to 146.9 +/- 8.8 cm (P less than 0.02) was seen in the placebo group. Side-effects were predominantly gastrointestinal and equally distributed in the two groups. It is concluded that a dietary fibre supplement is of value in the management of overweight, enhancing weight loss and decreasing hunger feelings.
Authors:
D Rigaud; K R Ryttig; L A Angel; M Apfelbaum
Related Documents :
23127308 - Falls in people with ms who use a walking aid: prevalence, factors and effect of balanc...
17006118 - Identification of patients with childhood moyamoya diseases showing temporary hypertens...
18625158 - Should chlorthalidone be the diuretic of choice for antihypertensive therapy?
2522008 - Safety and efficacy of amlodipine added to hydrochlorothiazide therapy in essential hyp...
18829698 - Development of methodology for conducting clinical trials in frontotemporal lobar degen...
2889438 - Cognitive dysfunction, negative symptoms, and tardive dyskinesia in schizophrenia. thei...
Publication Detail:
Type:  Clinical Trial; Journal Article; Randomized Controlled Trial    
Journal Detail:
Title:  International journal of obesity     Volume:  14     ISSN:  -     ISO Abbreviation:  Int J Obes     Publication Date:  1990 Sep 
Date Detail:
Created Date:  1990-12-04     Completed Date:  1990-12-04     Revised Date:  2014-06-03    
Medline Journal Info:
Nlm Unique ID:  7703240     Medline TA:  Int J Obes     Country:  ENGLAND    
Other Details:
Languages:  eng     Pagination:  763-9     Citation Subset:  IM    
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:
Adult
Blood Pressure
Diet, Reducing*
Dietary Fiber / therapeutic use*
Double-Blind Method
Energy Intake
Female
Humans
Hunger
Male
Obesity / drug therapy,  therapy*
Placebos
Chemical
Reg. No./Substance:
0/Placebos

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  Human skeletal muscle Na, K-ATPase concentration quantified by 3H-ouabain binding to intact biopsies...
Next Document:  N-myc oncogene amplification in paediatric tumours.